These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33464748)

  • 1. S100/CD34-Positive Spindle Cell Mesenchymal Neoplasm Harboring KIAA1549-BRAF Fusion.
    Paton DJW; Wong D; Amanuel B; Cheah K; Ardakani NM
    Am J Dermatopathol; 2021 Mar; 43(3):217-220. PubMed ID: 33464748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF-rearranged spindle cell mesenchymal neoplasm with a predominant lipofibromatosis-like neural tumor pattern and co-expression of CD34, S100 protein, and markers associated with perineurial differentiation: A rare case with potential diagnostic pitfall.
    Sun K; Ru GQ; Zhao M
    J Cutan Pathol; 2022 Mar; 49(3):278-283. PubMed ID: 34632612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low-grade malignant soft tissue tumor with S100 and CD34 co-expression showing novel CDC42SE2-BRAF fusion with distinct features.
    Sheng SJ; Li JM; Zou YF; Peng XJ; Wang QY; Fang HS; Li X; Ding Y; Fan QH; Zhang ZH; Wei YZ; Gong QX
    Genes Chromosomes Cancer; 2020 Oct; 59(10):595-600. PubMed ID: 32447786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.
    Subbiah V; Westin SN; Wang K; Araujo D; Wang WL; Miller VA; Ross JS; Stephens PJ; Palmer GA; Ali SM
    J Hematol Oncol; 2014 Jan; 7():8. PubMed ID: 24422672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous ALK rearranged spindle cell neoplasm and S-100/CD34 co-expression: report of a case].
    Zhang W; Wang Y; Wang H; Gao Y; Chen YL
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):498-500. PubMed ID: 38678336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of S100+ CD34+ spindle cell neoplasm with BRAF-KIAA1549 fusion in a metacarpal bone of an adult.
    Marasco S; Di Bella C; Slavin JL; McKelvie PA
    Pathology; 2023 Aug; 55(5):715-718. PubMed ID: 36842874
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions.
    Kojima N; Mori T; Motoi T; Kobayashi E; Yoshida M; Yatabe Y; Ichikawa H; Kawai A; Yonemori K; Antonescu CR; Yoshida A
    Mod Pathol; 2023 Apr; 36(4):100083. PubMed ID: 36788089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
    Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
    Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors.
    Choo F; Rakheja D; Davis LE; Davare M; Park JY; Timmons CF; Neff T; Beadling C; Corless CL; Davis JL
    Genes Chromosomes Cancer; 2021 Sep; 60(9):623-630. PubMed ID: 34036664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion.
    Abs D; Landman S; Osio A; Lepesant P; Schneider P; Obadia D; Moguelet P; Farges C; Poirot B; Lehmann-Che J; Lebbé C; Battistella M
    J Cutan Pathol; 2021 Jul; 48(7):896-901. PubMed ID: 33241586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle cell tumour with S100 and CD34 co-expression showing PDZRN3-RAF1 rearrangement - a recently described entity.
    Mok Y; Kimpo MS; Chen H; Kuick CH; Chang KT; Lee VKM
    Histopathology; 2019 Jun; 74(7):1109-1111. PubMed ID: 30742323
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
    Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
    Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
    Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
    Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.
    Panse G; Reisenbichler E; Snuderl M; Wang WL; Laskin W; Jour G
    J Cutan Pathol; 2021 Feb; 48(2):290-294. PubMed ID: 32519338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100 and CD34 positive spindle cell tumor with prominent perivascular hyalinization and a novel NCOA4-RET fusion.
    Michal M; Ptáková N; Martínek P; Gatalica Z; Kazakov DV; Michalová K; Stoláriková L; Švajdler M; Michal M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):680-685. PubMed ID: 30938880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
    Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
    J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.